Carroll uses Twitter, a New York Times column, blog post, podcast, videos and books to publish his findings on just about any health issue he thinks needs explaining or correcting.
Several diabetes and health care advocacy groups on Thursday announced a seven-figure fundraising campaign to help fund their fight against what they consider “skyrocketing” insulin prices.
In recent months, the drugmaker has won federal approval to sell a drug called Emgality for two conditions: migraine pain and cluster headaches.
It’s the second approved use for Emgality, which first won U.S. approval last fall to treat migraines. Analysts predict it could become a blockbuster.
To recognize the contribution, Eskenazi Health is changing the name of Midtown Community Mental Health to the Sandra Eskenazi Mental Health Center.
The medical field’s lofty dreams of unleashing the power of artificial intelligence to transform medicine have yet to materialize in a major way.
Two out-of-state companies that want to build a 60-bed hospital in Carmel have a history of mass layoffs, at least one high-profile bankruptcy, and accusations of kickbacks and billing irregularities.
Indiana will recognize nursing licenses from most other states with a new law taking effect this summer.
Bioanalytical Systems said May 1 it purchased Smithers Avanza Toxicology Services in suburban Washington, D.C.
Panelists from a broad range of life sciences fields shared their insights on key issues during IBJ's Life Sciences Power Breakfast on May 3.
Backed by more than $100 million in funding from Indiana companies and foundations, the Indiana Biosciences Research Institute has hired 39 employees and hopes to ramp up to 80 within another three years.
The seller was The Sanders Trust of Birmingham, Alabama. The trust—co-founded by Hall of Fame National Football League quarterback Bart Starr—acquired the building in 2009.
Kansas-based Aratana Therapeutics has three treatments approved by the U.S. Food and Drug Administration and is working on drugs for a range of disease fields, including cancer.
The city’s newest park is springing up on the south side of downtown, a district quickly filling up with apartments, offices and retail—and a noticeable shortage of public green space.
The nation's second largest insurer said Wednesday that enrollment in its fully-insured coverage jumped more than 6%, to 15.3 million.
Hospitals and patients have sued to block a new nationwide liver transplant policy that they say will waste viable livers, lead to fewer transplants and likely cause deaths.
Senate Majority Leader Mitch McConnell said Thursday his bill will cover all tobacco products, including vaping devices.
Long a leader in diabetes and neuroscience drugs, Eli Lilly and Co. is pushing hard and spending record sums to turbocharge its oncology business, potentially a huge growth area.
Little progress has been made in replacing Anthem Inc. in the Monument Circle building that, until the end of last year, served as headquarters for the Indianapolis-based health insurance giant.
